Semiquantitative comparison of the DNA-binding activity of in vitro- synthesized proteins

BioTechniques

Volumn 23, Issue 5, 1997, Pages 792-794

  Chène, Patrick ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; PROTEIN P53;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DNA BINDING; PROTEIN SYNTHESIS; QUANTITATIVE ASSAY; RABBIT; RETICULOCYTE LYSATE; RNA TRANSLATION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 19244384748     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/97235bm05     Document Type: Article

References (4)

1. El-Deiry, W.F., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
2. Hupp, T.R., D.W. Meek, C.A. Midgley and D.P. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71:875-886.
3. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 277:680-683.
4. Sambrook, J., E.F. Fritsch and T. Maniatis. Molecular Cloning: A Laboratory Manual, 2nd ed. CSH Laboratory Press, Cold Spring Harbor, NY.